Petros Grivas, MD, PhD

Dr. Petros Grivas MD, PhD

Petros Grivas, MD, PhD

Clinical Research Division, Fred Hutch

Fax: 206.606.1943
Mail Stop: LG-465

Dr. Petros Grivas is an oncologist with expertise in treating genitourinary cancers such as bladder cancer, prostate cancer and testicular cancer. His clinical research helped lead to FDA approval of new drugs to treat the most common type of bladder cancer. Dr. Grivas currently leads clinical trials that investigate the use of checkpoint inhibitors. These immunotherapy drugs release the brakes on a patient’s immune system and help it mount a better response to cancer. 

Other Appointments & Affiliations

Clinical Director
Genitourinary Cancers Program, University of Washington Medicine

Professor, Department of Medicine
Division of Oncology, University of Washington School of Medicine


Fellowship, Hematology/Oncology, University of Michigan

Residency, Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA

PhD, Medical Oncology, University of Patras School of Medicine, Greece

MD, University of Patras School of Medicine, Greece

Find an Active Clinical Trial Led by Dr. Grivas

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210